MD Anderson’s Gastrointestinal Center gives you exemplary, customized carcinoid tumor care every step of the way. Our specialized teams of experts collaborate and communicate with each other – and with you – to ensure the most-advanced treatments with the least impact on your body. And they have at their fingertips the latest innovative technology and methods to diagnose and treat carcinoid tumors, including specialized diagnostic methods and surgical techniques, and targeted therapies.
As one of the nation’s largest cancer centers, MD Anderson sees more patients with this complex type of cancer than most others. This gives us extraordinary expertise and experience, which translates into higher rates of successful outcomes for carcinoid tumors.
And at MD Anderson you’re surrounded by the strength of one of the nation’s largest and most experienced comprehensive cancer centers, which has all the support and wellness services needed to treat the whole person – not just the disease.
As one of the world’s largest cancer research centers, MD Anderson is leading the investigation into new methods of carcinoid tumor diagnosis and treatment. For instance, our researchers are studying carcinoid tumors on a molecular basis to try to find a cause.
Our status as a premier research center means we can offer clinical trials (research studies) of new treatments for carcinoid tumors. MD Anderson researchers have led the development of novel treatment strategies, including targeting of mTOR (a protein) and angiogenesis (growth of new blood vessels) in neuroendocrine tumors (including carcinoid tumors). MD Anderson researchers were involved from proof-of-concept single institution phase II to multi-national phase III studies.
If you have been diagnosed with a carcinoid tumor, it is important to be seen by expert doctors. We can help. Call 1-877-632-6789 to make an appointment or request an appointment online.
Why Choose MD Anderson?
- Advanced carcinoid tumor treatments including targeted therapies, specialized surgical techniques and octreotide
- Focused diagnostic methods including high-resolution CT scan, nuclear imaging (OctreoScan™), endoscopic ultrasound and capsule endoscopy
- Skilled surgeons, innovative techniques
- Team approach includes specialists with high levels of experience treating carcinoid tumors
- Clinical trials of new carcinoid tumor treatments
Carcinoid Tumor Knowledge Center
"When I’m talking to someone with this rare cancer, they say I helped them not feel so alone. Just that human contact with someone who has had it and survived makes a difference."
Carcinoid Tumor Facts
Between 11,000 and 12,000 people in the United States are diagnosed each year with carcinoid tumors. Carcinoid tumors also are called neuroendocrine tumors or cancers. The number of people with carcinoid tumors has been increasing in the past few years. This probably is because of the increase of endoscopy and CT scans to screen for or diagnose other issues.
This slow-growing type of cancer can start in any part of the body that has neuroendocrine cells. These cells receive signals from the nervous system and then release hormones into the blood. Carcinoid tumors are most common in the gastrointestinal (GI) tract and the lungs.
The average age of people diagnosed with carcinoid tumors is the early 60s. Carcinoid tumors are more common in African-Americans than in whites. They are slightly more common in women than men. A GI carcinoid tumor makes you more likely to have other digestive system cancers.